Technological innovations in human enhancement

These wearables, available in 2026, transform personal health monitoring by integrating Samsung's AI (Galaxy AI). They analyze data from both devices to generate 'Energy Score' reports and health trends, interpreting, correlating, and predicting health problems before they become symptoms.

The Apple Watch Series 10, available in 2026, consolidates its position as the most comprehensive health wearable thanks to its integration with Apple Intelligence. Its advanced AI not only collects data but intelligently interprets it to offer significant alerts, improving proactive health monitoring.

Whoop, evolving in 2026, is positioned as a portable medical assistant by transitioning from a sports wearable to a digital health platform. It offers advanced and personalized health monitoring, with a focus on prevention and overall well-being, including blood analysis and female hormonal tracking.

Neuralink's brain implants are crucial for their ability to allow people with severe paralysis to control digital devices with their thoughts. With human trials initiated in 2024 and large-scale manufacturing plans in 2026, they represent a significant advance in the direct connection between the human brain and technology.

This system represents a milestone as the first Class III implantable BCI device authorized for commercial use worldwide. Its approval marks the transition of BCI technology from research to large-scale clinical application, offering a basis for wider adoption in neurorehabilitation.

This wireless brain implant with micro-LEDs, developed in late 2025, offers an innovative alternative for sensory restoration. By transmitting information directly to the cerebral cortex using light, it bypasses natural sensory pathways and allows precise communication with the brain without bulky wires.

Able Human Motion's robotic exoskeleton, presented at Mobile World Congress 2026, is a current and in-use solution for rehabilitation and mobility enhancement. It is designed to help patients with neurological injuries regain their gait, demonstrating its effectiveness in various centers.

The incorporation of this robotic exoskeleton at the Enfermera Isabel Zendal Hospital in March 2026 marks a pioneering advance in the treatment of ALS. It is the first time in the world that this type of device has been used in this population, allowing for safer and more adapted therapies.

The VIATRIX Exoskeleton Robot, presented at CES 2026, marks the entry of exoskeletons into the consumer market. It offers intelligent and adaptive mobility assistance for outdoor life, extending the benefits of this technology beyond clinical rehabilitation.

The definitive blueprints for open-source exoskeletons, released in March 2026, democratize access to mobility assistance technology. They enable the manufacture of assisted standing devices for less than 500 euros, making them affordable and accessible to a much wider audience.

These bionic leg prostheses, available in 2026, offer advanced functionality that dynamically adapts to the user. Their microprocessor-controlled knees and motorized ankles improve the naturalness and efficiency of gait for people with amputations, integrating sensors that detect movement intention.

Bionic myoelectric hands with sensory feedback, evolving in 2026, improve the precision and control of prostheses. They integrate proximity and pressure sensors to anticipate object distance and adjust finger position, making tasks more intuitive and less strenuous.

Personalized genetic editing with CRISPR, with therapies under development and clinical trials in 2026, promises to transform personalized medicine. It allows for the correction of specific mutations in each patient's genome to treat rare diseases, with more precise and efficient versions that reduce off-target effects.

Gene therapies to reverse aging, with human clinical trials planned for 2026 by Harvard Medical School, represent one of the most promising research areas in human enhancement. Based on epigenome manipulation, they have the potential to transform preventive medicine and life expectancy.

These devices, with cutting-edge applications in 2026, offer an innovative therapeutic tool in cognitive psychology. They allow patients with ADHD and anxiety disorders to visualize their brain waves in real time, facilitating conscious self-regulation and reducing pharmacological dependence.

These systems, possible in 2026, allow for early and preventive intervention in mental health. Through the analysis of biometric and neural data, they identify episodes of depressive crises or psychotic outbreaks before the patient verbally manifests them, significantly improving prognosis and quality of life.

Zirconia ceramic dental implants, gaining ground in 2026, provide an aesthetically superior and biocompatible alternative for dental enhancement. They offer greater biocompatibility and a color closer to the natural tooth compared to titanium implants, making them ideal for visible areas and patients with metal sensitivity.

Continuous improvements in dental implants with nanostructured coatings in 2026 accelerate the osseointegration process and reduce the risk of complications. These coatings promote osteoblast adhesion, and advanced surface treatments reduce contamination, leading to greater long-term reliability.